Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Monday, July 10, 2023

Moderna Valuation. July 2023

 

Moderna is currently, short-term overvalued.

Long-term, Moderna's intrinsic value is 300 billion USD compared to the current circa 45 billion USD Moderna market capitalization on the potential of messenger RNA, mRNA technology.

Messenger RNA or mRNA is the future of technology in the medicine and Moderna is the leading mRNA biotechnology pioneer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)